RxDoctor Payments Data

Ana Burga, MD

Anatomic Pathology & Clinical Pathology · Englewood, NJNPI 1285685909

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $4,926 of the $7,606 with a category attached, or 64.8%. Novartis accounts for 92.0% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2019 at $7,007 and has fallen 97.6% since, to $169 in 2025. Among anatomic pathology & clinical pathology clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,606in general payments, 2019–2025

Across 26 payments — averaging $292.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$7K
  • AbbVie$264
  • AstraZeneca$119
  • Daiichi Sankyo Inc.$71
  • Hemosonics LLC$37
  • Lilly USA, LLC$37
  • plus $81 from 4 others

What the payments were for

  • Consulting fees$1,25416%
  • Speaking & faculty fees$4,92665%
  • Travel & lodging$6539%
  • Food & beverage$77210%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,606 in reported general payments places this provider in the 95th percentile of 218 anatomic pathology & clinical pathology providers in New Jersey.

See all anatomic pathology & clinical pathology providers in New Jersey

Medicare billing

Part B allowed, 2024
$52,066
Medicare patients
458
Services billed
1,325

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in Englewood

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →